Evidence map›Paper›PMID 35169671›Full record

ArticleEnvironmental epidemiology (Philadelphia, Pa.)2022

The EXIMIOUS project-Mapping exposure-induced immune effects: connecting the exposome and the immunome.

Steven Ronsmans, Karin Sørig Hougaard, Tim S Nawrot, Michelle Plusquin, François Huaux, María Jesús Cruz, Horatiu Moldovan, Steven Verpaele, Murali Jayapala, Michael Tunney and 13 more

Open access · goldAbstract read
In one paragraph

Article in Environmental epidemiology (Philadelphia, Pa.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Global research trends on the human exposome: a bibliometric analysis (2005-2024).Environmental science and pollution research international · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 13 institutions in 7 countries.

Steven RonsmansCentre for Environment and Health, KU Leuven, Leuven, Belgium.
Karin Sørig HougaardNational Research Centre for the Working Environment, Copenhagen, Denmark.
Tim S NawrotCentre for Environment and Health, KU Leuven, Leuven, Belgium.
Michelle PlusquinCentre for Environmental Sciences, University of Hasselt, Hasselt, Belgium.
François HuauxLouvain Centre for Toxicology and Applied Pharmacology, Université Catholique de Louvain, Brussels, Belgium.
María Jesús CruzVall d'Hebron Research Institute, Barcelona, Catalonia, Spain.
Horatiu MoldovanUniversity of Medicine, Pharmacy, Science and Technology of Targu Mureş, Targu Mureş, Romania.
Steven VerpaeleBelgian Center for Occupational Hygiene, Zwijnaarde, Belgium.
Murali Jayapalaimec (Interuniversitair Microelectronica Centrum), Leuven, Belgium.
Michael TunneySchool of Pharmacy, Queen's University Belfast, Belfast, United Kingdom.
Stéphanie Humblet-BaronDepartment of Microbiology and Immunology, KU Leuven, Leuven, Belgium.
Hubert DirvenDepartment of Environmental Health, Norwegian Institute of Public Health, Oslo, Norway.
Unni Cecilie NygaardDepartment of Environmental Health, Norwegian Institute of Public Health, Oslo, Norway.
Birgitte LindemanDepartment of Environmental Health, Norwegian Institute of Public Health, Oslo, Norway.
Nur DualeDepartment of Environmental Health, Norwegian Institute of Public Health, Oslo, Norway.
Adrian ListonLaboratory of Lymphocyte Signalling and Development, The Babraham Institute, Babraham Research Campus, Cambridge, CB22 3AT United Kingdom.
Esben Meulengracht FlachsRegion Hovedstaden, Copenhagen, Denmark.
Kenneth KastaniegaardBiogenity ApS, Aalborg, Denmark.
Matthias KetzelSection of Atmospheric Modelling, Department of Environmental Science, Aarhus University, Aarhus, Denmark.
Julia Goetzaccelopment AG, Zurich, Switzerland.
Jeroen VanoirbeekCentre for Environment and Health, KU Leuven, Leuven, Belgium.
Manosij GhoshCentre for Environment and Health, KU Leuven, Leuven, Belgium.
Peter H M HoetCentre for Environment and Health, KU Leuven, Leuven, Belgium.
KU Leuven · BENorwegian Institute of Public Health · NOHasselt University · BEAarhus University · DKAccelopment (Switzerland) · CHBabraham Institute · GBCapital Region of Denmark · DKIMEC · BENational Research Centre for the Working Environment · DKQueen's University Belfast · GBUCLouvain · BEUniversitatea de Medicină, Farmacie, Științe și Tehnologie „George Emil Palade” din Târgu Mureș · ROVall d'Hebron Institut de Recerca · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Immune-mediated, noncommunicable diseases-such as autoimmune and inflammatory diseases-are chronic disorders, in which the interaction between environmental exposures and the immune system plays an important role. The prevalence and societal costs of these diseases are rising in the European Union. The EXIMIOUS consortium-gathering experts in immunology, toxicology, occupational health, clinical medicine, exposure science, epidemiology, bioinformatics, and sensor development-will study eleven European study populations, covering the entire lifespan, including prenatal life. Innovative ways of characterizing and quantifying the exposome will be combined with high-dimensional immunophenotyping and -profiling platforms to map the immune effects (immunome) induced by the exposome. We will use two main approaches that "meet in the middle"-one starting from the exposome, the other starting from health effects. Novel bioinformatics tools, based on systems immunology and machine learning, will be used to integrate and analyze these large datasets to identify immune fingerprints that reflect a person's lifetime exposome or that are early predictors of disease. This will allow researchers, policymakers, and clinicians to grasp the impact of the exposome on the immune system at the level of individuals and populations.

Indexed as

External exposomeImmune-mediated diseasesImmunomeMulti-omics

Identifiers

PMID35169671
PMCPMC8835560
OpenAlexW4210718459

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.